COM:ZAILABORATORY
Zai Lab
- Stock
locale
Chinamarket
STOCKSindustry
Biopharmaceuticalwebsite
www.zailaboratory.comipo date
Sep 20, 2017
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin ...Show More